Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maize Research Institute "Zemun Polje" (MRIZP) is a leading Serbian scientific institution specializing in the research, breeding, and commercialization of maize and soybean hybrids. Founded in 1945, the institute integrates classical plant breeding with modern molecular biotechnology to develop high-yielding, stress-tolerant crop varieties marketed under the "ZP" brand. Its operations encompass genetic research, seed production, and food technology, with a focus on enhancing the nutritional quality of grains. MRIZP is a key player in the European agricultural sector, exporting its proprietary seed technology to over 20 countries. The institute also provides expert services in seed testing and quality control, maintaining a significant role in regional food security.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maize Research Institute.